FDA Inspection 1236215 — Agera Tobacco, Inc.

Agera Tobacco, Inc. — FEI 3013600570

The FDA completed an inspection of Agera Tobacco, Inc. on Mar 6, 2024 in Anaheim, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Tobacco.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 6, 2024
Fiscal Year
2024
Product Type
Tobacco
Project Area
Tobacco Post-Market Activities
Location
Anaheim, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.